References
- 1Joseph P, Leong D, McKee M, Anand SS, Schwalm J-D, Teo K, Mente A, Yusuf S. Reducing the global burden of cardiovascular disease, part 1: The epidemiology and risk factors. Circulation Research. 2017;121:677–694. DOI: 10.1161/CIRCRESAHA.117.308903
- 2Warren-Gash C, Smeeth L, Hayward AC. Influenza as a trigger for acute myocardial infarction or death from cardiovascular disease: A systematic review. The Lancet Infectious Diseases. 2009;9:601–610. DOI: 10.1016/S1473-3099(09)70233-6
- 3Clayton TC, Thompson M, Meade TW. Recent respiratory infection and risk of cardiovascular disease: Case-control study through a general practice database. European Heart Journal. 2008;29:96–103. DOI: 10.1093/eurheartj/ehm516
- 4Kwok CS, Aslam S, Kontopantelis E, Myint PK, Zaman MJ, Buchan I, Loke YK, Mamas MA. Influenza, influenza-like symptoms and their association with cardiovascular risks: A systematic review and meta-analysis of observational studies. International Journal of Clinical Practice. 2015;69:928–937. DOI: 10.1111/ijcp.12646
- 5Madjid M, Miller CC, Zarubaev VV, Marinich IG, Kiselev OI, Lobzin YV, Filippov AE, Casscells, SW
III. . Influenza epidemics and acute respiratory disease activity are associated with a surge in autopsy-confirmed coronary heart disease death: Results from 8 years of autopsies in 34,892 subjects. European Heart Journal. 2007;28:1205–1210. DOI: 10.1093/eurheartj/ehm035 - 6Kwong JC, Schwartz KL, Campitelli MA, Chung H, Crowcroft NS, Karnauchow T, Katz K, Ko DT, McGeer AJ, McNally D, et al. Acute myocardial infarction after laboratory-confirmed influenza infection. The New England Journal of Medicine. 2018;378:345–353. DOI: 10.1056/NEJMoa1702090
- 7Hung IF, Leung AY, Chu DW, Leung D, Cheung T, Chan CK, Lam CL, Liu SH, Chu CM, Ho PL, et al. Prevention of acute myocardial infarction and stroke among elderly persons by dual pneumococcal and influenza vaccination: A prospective cohort study. Clinical Infectious Diseases. 2010;51:10071016. DOI: 10.1086/656587
- 8Nichol KL. Influenza vaccination in the elderly: Impact on hospitalization and mortality. Drugs & Aging. 2005;22:495–515. DOI: 10.2165/00002512-200522060-00004
- 9Nichol KL, Margolis KL, Wuorenma J, Von Sternberg T. The efficacy and cost effectiveness of vaccination against influenza among elderly persons living in the community. The New England Journal of Medicine. 1994;331:778–784. DOI: 10.1056/NEJM199409223311206
- 10Nichol KL, Nordin J, Mullooly J, Lask R, Fillbrandt K, Iwane M. Influenza vaccination and reduction in hospitalizations for cardiac disease and stroke among the elderly. The New England Journal of Medicine. 2003;348:1322–1332. DOI: 10.1056/NEJMoa025028
- 11Bridges CB, Fukuda K, Uyeki TM, Cox NJ, Singleton JA, Centers for Disease Control and Prevention; Advisory Committee on Immunization Practices. Prevention and control of influenza: Recommendations of the Advisory Committee on Immunization Practices (ACIP). Morbidity and Mortality Weekly Recommendations and Report. 2002;51:1–31.
- 12Udell JA, Zawi R, Bhatt DL, Keshtkar-Jahromi M, Gaughran F, Phrommintikul A, Ciszewski A, Vakili H, Hoffman EB, Farkouh ME, et al. Association between influenza vaccination and cardiovascular outcomes in high-risk patients: A meta-analysis. JAMA. 2013;310:1711–1720. DOI: 10.1001/jama.2013.279206
- 13Clar C, Oseni Z, Flowers N, Keshtkar-Jahromi M, Rees K. Influenza vaccines for preventing cardiovascular disease. Cochrane Database of Systematic Reviews. 2015;CD005050. DOI: 10.1002/14651858.CD005050.pub3
- 14LeBras MH, Barry AR. Influenza vaccination for secondary prevention of cardiovascular events: A systematic review. Canadian Journal of Hospital Pharmacy. 2017;70:27–34. DOI: 10.4212/cjhp.v70i1.1626
- 15Lamontagne F, Garant MP, Carvalho JC, Lanthier L, Smieja M, Pilon D. Pneumococcal vaccination and risk of myocardial infarction. Canadian Medical Association Journal. 2008;179:773–777. DOI: 10.1503/cmaj.070221
- 16Vila-Corcoles A, Ochoa-Gondar O, Rodriguez-Blanco T, Gutierrez-Perez A, Vila-Rovira A, Gomez F, Raga X, de Diego C, Satue E, Salsench E, et al. Clinical effectiveness of pneumococcal vaccination against acute myocardial infarction and stroke in people over 60 years: The CAPAMIS study, one-year follow-up. BMC Public Health. 2012;12:222. DOI: 10.1186/1471-2458-12-222
- 17Rodrigues BS, David C, Costa J, Ferreira JJ, Pinto FJ, Caldeira D. Influenza vaccination in patients with heart failure: A systematic review and meta-analysis of observational studies. Heart. 2020;106:350–357. DOI: 10.1136/heartjnl-2019-315193
- 18Davis BM, Black D. Identifying the challenges to adult influenza vaccination in Latin America. Value in Health. 2017;20:PA934. DOI: 10.1016/j.jval.2017.08.2951
- 19Zimmerman RK, Santibanez TA, Fine MJ, Janosky JE, Nowalk MP, Bardella IJ, Raymund M, Wilson SA. Barriers and facilitators of pneumococcal vaccination among the elderly. Vaccine. 2003;21:1510–1517. DOI: 10.1016/S0264-410X(02)00698-9
- 20Centers for Disease Control and Prevention (CDC). Reasons reported by Medicare beneficiaries for not receiving influenza and pneumococcal vaccinations–United States, 1996. Morbidity and Mortality Weekly Recommendations and Report. 1999;48:886–890.
- 21Centers for Disease Control. Adult immunization: Knowledge, attitudes, and practices—DeKalb and Fulton Counties, Georgia, 1988. JAMA. 1988;260:3253–3255. DOI: 10.1001/jama.1988.03410220023007
- 22Bovier PA, Chamot E, Bouvier Gallacchi M, Loutan L. Importance of patients’ perceptions and general practitioners’ recommendations in understanding missed opportunities for immunisations in Swiss adults. Vaccine. 2001;19:4760–4767. DOI: 10.1016/S0264-410X(01)00223-7
- 23Schmid P, Rauber D, Betsch C, Lidolt G, Denker ML. Barriers of influenza vaccination intention and behavior—A systematic review of influenza vaccine hesitancy, 2005–2016. PLoS One. 2017;12:
e0170550 . DOI: 10.1371/journal.pone.0170550 - 24Burki TK. Vaccine misinformation and social media. The Lancet Digital Health. 2019;1:E258–E259. DOI: 10.1016/S2589-7500(19)30136-0
- 25Hill JA, Agewall S, Baranchuk A, Booz GW, Borer JS, Camici PG, Chen PS, Dominiczak AF, Erol Ç, Grines CL, et al. Medical misinformation: Vet the message! International Journal of Cardiology. 2019;277:1–2. DOI: 10.1016/j.ijcard.2018.12.071
- 26Chan MS, Jamieson KH, Albarracin D. Prospective associations of regional social media messages with attitudes and actual vaccination: A big data and survey study of the influenza vaccine in the United States. Vaccine. 2020;38:6236–6247. DOI: 10.1016/j.vaccine.2020.07.054
- 27Sosa Liprandi Á, Zaidel EJ, Lopez Santi R, Araujo JJ, Baños González MA, Busso JM, Cabral L, Camilletti J, Erriest J, Flores R, et al. Influenza and pneumococcal vaccination in non-infected cardiometabolic patients from the Americas during the COVID-19 pandemic. A sub-analysis of the CorCOVID-LATAM study. Vaccines. 2021;9:123. DOI: 10.3390/vaccines9020123
- 28Liprandi AS, Liprandi MIS, Zaidel EJ, Aisenberg GM, Baranchuk A, Barbosa ECD, Sánchez GB, Alexander B, Zanetti FTL, Santi RL, Múnera-Echeverri AG, et al. Influenza vaccination for the prevention of cardiovascular disease in the Americas: Consensus document of the Inter-American Society of Cardiology and the Word Heart Federation. Global Heart. 2021;16(1):55. DOI: 10.5334/gh.1069
- 29Santi RL, Márquez MF, Piskorz D, Saldarriaga C, Lorenzatti A, Wyss F, Martín AV, Perales JS, Arcela JC, de Lourdes Rojas Gimon E, Sambadaro G, Perez GE, Mendoza I, Lanas F, Flores R, Liprandi AS, Alexander B, Baranchuk A. Ambulatory patients with cardiometabolic disease and without evidence of COVID-19 during the pandemic. The CorCOVID LATAM study. Global Heart. 2021;16(1):15. DOI: 10.5334/gh.932
- 30Wyss F, Lopez-Santi R, Piskorz D, Gupta S, Munera-Echeverri A, Lopez-Santi P, Piskorz G, Ullauri V, Gomez JE, Sueldo MD, et al. Immunization and cardiovascular disease in Latin America. The CorVacc study: Rationale and design. Archivos de Cardiología de Mexico. 2025;95(3):144–152. DOI: 10.24875/ACM.24000239
- 31Black CL, Kriss JL, Razzaghi H, Patel SA, Santibanez TA, Meghani M, Tippins A, Stokley S, Chatham-Stephens K, Dowling NF, et al. Influenza, updated COVID-19, and respiratory syncytial virus vaccination coverage among adults – United States, Fall 2023. Morbidity and Mortality Weekly Recommendations and Report. 2023;72(51):1377–1382. DOI: 10.15585/mmwr.mm7251a4
- 32Aldhahir AM, Alyami MM, Alasimi AH, Alqahtani AM, Mousa RE, Alqahtani SA, Alhalbub LM, Mohammed OA, Alosaimi SM, AlQahtani AS, et al. Awareness, uptake, and barriers to vaccination against respiratory tract infections in patients with diabetes mellitus: A multi-center study in Saudi Arabia. Human Vaccines & Immunotherapeutics. 2025;21(1):2585544. DOI: 10.1080/21645515.2025.2585544
- 33Liu D, Zhang Y, Lei J, Li J, Xiang C, Peng Y, Hu Y, Fang L, Feng L, Shan G, et al. Influenza, pneumococcal, COVID-19 vaccine willingness and uptake with influencing factors in 38,184 Chinese older adults in 2022: A nationwide cross-sectional study. Vaccine. 2025;68:127961. DOI: 10.1016/j.vaccine.2025.127961
- 34Balsamo D, Offeddu V, Aghamohammadi Z, Chiavenna C, Leone LP, D’Agnese E, Sharma D, Torbica A, Shayegh S, Andreu-Perez J, Melegaro A. Mapping inequities in global vaccine sentiment research. BMJ Global Health. 2025;10(11):
e018587 . DOI: 10.1136/bmjgh-2024-018587